Boateng CA - Search Results

1

Benzothieno[3,2-b]quinolinium and 3-(phenylthio)quinolinium compounds: Synthesis and evaluation against opportunistic fungal pathogens.

Boateng CA, Eyunni SV, Zhu XY, Etukala JR, Bricker BA, Ashfaq MK, Jacob MR, Khan SI, Walker LA, Ablordeppey SY. Boateng CA, et al. Bioorg Med Chem. 2011 Jan 1;19(1):458-70. doi: 10.1016/j.bmc.2010.11.008. Epub 2010 Nov 10. Bioorg Med Chem. 2011. PMID: 21134759 Free PMC article.

2

Optimization of 3-(phenylthio)quinolinium compounds against opportunistic fungal pathogens.

Boateng CA, Zhu XY, Jacob MR, Khan SI, Walker LA, Ablordeppey SY. Boateng CA, et al. Eur J Med Chem. 2011 May;46(5):1789-97. doi: 10.1016/j.ejmech.2011.02.034. Epub 2011 Feb 23. Eur J Med Chem. 2011. PMID: 21402432 Free PMC article.

3

CoMFA studies and in vitro evaluation of some 3-substituted benzylthio quinolinium salts as anticryptococcal agents.

Bolden S, Boateng CA, Zhu XY, Etukala JR, Eyunni SK, Jacob MR, Khan SI, Ablordeppey SY. Bolden S, et al. Among authors: boateng ca. Bioorg Med Chem. 2013 Nov 15;21(22):7194-201. doi: 10.1016/j.bmc.2013.08.043. Epub 2013 Sep 3. Bioorg Med Chem. 2013. PMID: 24080102 Free PMC article.

4

Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents.

Bolden S Jr, Zhu XY, Etukala JR, Boateng C, Mazu T, Flores-Rozas H, Jacob MR, Khan SI, Walker LA, Ablordeppey SY. Bolden S Jr, et al. Eur J Med Chem. 2013;70:130-42. doi: 10.1016/j.ejmech.2013.09.044. Epub 2013 Oct 5. Eur J Med Chem. 2013. PMID: 24141203 Free PMC article.

5

Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D₃ Receptor.

Michino M, Boateng CA, Donthamsetti P, Yano H, Bakare OM, Bonifazi A, Ellenberger MP, Keck TM, Kumar V, Zhu C, Verma R, Deschamps JR, Javitch JA, Newman AH, Shi L. Michino M, et al. Among authors: boateng ca. J Med Chem. 2017 Jan 26;60(2):580-593. doi: 10.1021/acs.jmedchem.6b01148. Epub 2017 Jan 5. J Med Chem. 2017. PMID: 27983845 Free PMC article.

6

Dopamine D₄ Receptor-Selective Compounds Reveal Structure-Activity Relationships that Engender Agonist Efficacy.

Keck TM, Free RB, Day MM, Brown SL, Maddaluna MS, Fountain G, Cooper C, Fallon B, Holmes M, Stang CT, Burkhardt R, Bonifazi A, Ellenberger MP, Newman AH, Sibley DR, Wu C, Boateng CA. Keck TM, et al. Among authors: boateng ca. J Med Chem. 2019 Apr 11;62(7):3722-3740. doi: 10.1021/acs.jmedchem.9b00231. Epub 2019 Apr 1. J Med Chem. 2019. PMID: 30883109 Free PMC article.

7

Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder.

Boateng CA, Nilson AN, Placide R, Pham ML, Jakobs FM, Boldizsar N, McIntosh S, Stallings LS, Korankyi IV, Kelshikar S, Shah N, Panasis D, Muccilli A, Ladik M, Maslonka B, McBride C, Sanchez MX, Akca E, Alkhatib M, Saez J, Nguyen C, Kurtyan E, DePierro J, Crowthers R, Brunt D, Bonifazi A, Newman AH, Rais R, Slusher BS, Free RB, Sibley DR, Stewart KD, Wu C, Hemby SE, Keck TM. Boateng CA, et al. J Med Chem. 2023 Sep 14;66(17):12141-12162. doi: 10.1021/acs.jmedchem.3c00734. Epub 2023 Aug 30. J Med Chem. 2023. PMID: 37646374 Free PMC article.

8

Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D₂/D₃ Receptor Bitopic Ligands.

Shaik AB, Boateng CA, Battiti FO, Bonifazi A, Cao J, Chen L, Chitsazi R, Ravi S, Lee KH, Shi L, Newman AH. Shaik AB, et al. Among authors: boateng ca. J Med Chem. 2021 Oct 28;64(20):15313-15333. doi: 10.1021/acs.jmedchem.1c01353. Epub 2021 Oct 12. J Med Chem. 2021. PMID: 34636551 Free PMC article.

9

High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.

Boateng CA, Bakare OM, Zhan J, Banala AK, Burzynski C, Pommier E, Keck TM, Donthamsetti P, Javitch JA, Rais R, Slusher BS, Xi ZX, Newman AH. Boateng CA, et al. J Med Chem. 2015 Aug 13;58(15):6195-213. doi: 10.1021/acs.jmedchem.5b00776. Epub 2015 Jul 23. J Med Chem. 2015. PMID: 26203768 Free PMC article.

10

The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.

You ZB, Gao JT, Bi GH, He Y, Boateng C, Cao J, Gardner EL, Newman AH, Xi ZX. You ZB, et al. Neuropharmacology. 2017 Nov;126:190-199. doi: 10.1016/j.neuropharm.2017.09.007. Epub 2017 Sep 6. Neuropharmacology. 2017. PMID: 28888944 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page